Generic Pharmaceuticals Company Investment Opportunity in Pune, India
10-year pharmaceutical distribution business seeks investment to complete 80%-built antibiotic injection manufacturing plant.
Premium Plan
| Established | 5-10 year(s) |
| Employees | 5 - 10 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 93 thousand |
| Run Rate Sales | USD 70 thousand |
| EBITDA Margin | 18 % |
| Industries | Generic Pharmaceuticals |
| Locations | Pune |
| Local Time | 3:05 PM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
230 thousand
for
15.0%
stake
(Native Currency: INR 20,000,000)
Reason: We are seeking this investment to complete our antibiotics injection manufacturing plant, as we are ...
View More
Includes physical assets worth
USD
580 thousand
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Not disclosed
User Verification
Documents
GST Registration Certificate
(131.2 KB)
Certificate of Incorporation
(595.2 KB)
Product Portfolio
(29.5 MB)
Business Overview
- Based in Pune, this pharmaceutical business specializes in the distribution of multiple antibiotic brands.
- The company's top-selling products, Meropenem and Ertapenem, are distributed to traders, hospitals, and pharmacists, showcasing a diverse customer base within the generic pharmaceuticals industry.
- The business experiences seasonality in sales but anticipates doubling its revenue during peak seasons over the next few months.
- Currently, the company caters to 4 to 5 main customers, highlighting the need for investment to expand its customer base and increase market penetration.
- The business plans to establish an antibiotic vial manufacturing unit, targeting a production capacity of 70k vials per day, aiming to become a contract manufacturer for leading pharmaceutical brands.
- With a confirmed working order worth INR 4 crore, the company is poised to boost production and considers international export as a strategic growth area, offering significant investment potential.
- The business holds a drug license, ensuring compliance with regulatory standards. The FDA license process is currently underway.
- The company's top-selling products, Meropenem and Ertapenem, are distributed to traders, hospitals, and pharmacists, showcasing a diverse customer base within the generic pharmaceuticals industry.
- The business experiences seasonality in sales but anticipates doubling its revenue during peak seasons over the next few months.
- Currently, the company caters to 4 to 5 main customers, highlighting the need for investment to expand its customer base and increase market penetration.
- The business plans to establish an antibiotic vial manufacturing unit, targeting a production capacity of 70k vials per day, aiming to become a contract manufacturer for leading pharmaceutical brands.
- With a confirmed working order worth INR 4 crore, the company is poised to boost production and considers international export as a strategic growth area, offering significant investment potential.
- The business holds a drug license, ensuring compliance with regulatory standards. The FDA license process is currently underway.
Products & Services Overview
The business distributes products for multiple antibiotic brands, with top-selling items including Meropenem and Ertapenem.The products are being sold to traders, hospitals, and pharmacists.
The business is looking to start an antibiotic vial manufacturing unit with plans to become an OEM for top pharmaceutical brands and also export its products internationally. Plans to primarily manufacture Carbapenem antibiotics.
Assets Overview
Tangible assets are valued at over INR 5 crore, including equipment, machinery, and constructed infrastructure for the manufacturing plant.
Facilities Overview
We are operating from a rented office.The manufacturing plant is being constructed on leased land measuring 17,000 sq. ft. , with a built-up area of 14,000 sq. ft (80% completed). It will feature an automatic dry powder injection filling line, a microbiology lab, and a quality control lab.
Capitalization Overview
Existing loans include an INR 8 lakh car loan, an INR 90 lakh machinery loan, and an INR 5 lakh credit line.The business has two directors, each holding a 50% stake.
Recent Activity
-
3 days, 1 hour agoChairman, Healthcare Services, Pune, Individual Investor / Buyer connected with the Business
-
3 days, 2 hours agoDirector, Real Estate, Badlapur, Individual Investor / Buyer connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
7 Investors contacted this Business this week.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 123,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses